Pharmacological Group
Latin name
Cefoxitinum ( сefoxitini).
Used in the treatment of
- N73.9 Female pelvic inflammatory disease, unspecified
- N39.0 Urinary tract infection, site not specified
- M86.9 Osteomyelitis, unspecified
- M79.8 Other specified soft tissue disorders
- M13.9 Arthritis, unspecified
- L08.9 Local infection of skin and subcutaneous tissue, unspecified
- J22 Unspecified acute lower respiratory infection
- J06 Acute upper respiratory infections of multiple and unspecified sites
- I38 Endocarditis, valve unspecified
- A49.9 Bacterial infection, unspecified
- R57.2 Septic shock
- T81.4 Infection following a procedure, not elsewhere classified
- Z29.2 Other prophylactic chemotherapy
- A41.9 Sepsis, unspecified
CAS Code
35607-66-0.
Analogs by action
- 72% Imipenem+Cilastatin [Imipenem]
- 69% Cefamandole
- 67% Cefradine
- 62% Cefotetan
- Show all
Included in the composition
- — Anaerocef (Пребенд ПФК ООО )
- — Boncefin
- — Cefoxitin (ДЕКО компания )
- — Cefoxitin Sodium (2 firms)
- — Cefoxitin sodium sterile (Ribbon )
- — Mefoxin
- — Амбицеф